nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—PLA2G4A—Epirubicin—pancreatic cancer	0.519	1	CbGbCtD
Suramin—F2—hepatic artery—pancreatic cancer	0.0464	0.334	CbGeAlD
Suramin—F2—portal vein—pancreatic cancer	0.0403	0.29	CbGeAlD
Suramin—P2RX4—islet of Langerhans—pancreatic cancer	0.00979	0.0706	CbGeAlD
Suramin—SIRT1—islet of Langerhans—pancreatic cancer	0.00858	0.0618	CbGeAlD
Suramin—F2—gall bladder—pancreatic cancer	0.00692	0.0499	CbGeAlD
Suramin—SIRT1—pancreas—pancreatic cancer	0.00603	0.0435	CbGeAlD
Suramin—SIRT1—digestive system—pancreatic cancer	0.00515	0.0371	CbGeAlD
Suramin—ARSA—digestive system—pancreatic cancer	0.00509	0.0367	CbGeAlD
Suramin—PLA2G2A—pancreas—pancreatic cancer	0.00422	0.0304	CbGeAlD
Suramin—PLA2G2A—digestive system—pancreatic cancer	0.00361	0.026	CbGeAlD
Suramin—F2—digestive system—pancreatic cancer	0.00272	0.0196	CbGeAlD
Suramin—PLA2G4A—Signaling Pathways—NRP1—pancreatic cancer	5.22e-05	0.000153	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PIK3CB—pancreatic cancer	5.22e-05	0.000153	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	5.21e-05	0.000152	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PIK3CA—pancreatic cancer	5.2e-05	0.000152	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—EGF—pancreatic cancer	5.19e-05	0.000152	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GLP1R—pancreatic cancer	5.18e-05	0.000151	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	5.18e-05	0.000151	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—DPYD—pancreatic cancer	5.09e-05	0.000149	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HEY1—pancreatic cancer	5.09e-05	0.000149	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SCT—pancreatic cancer	5.09e-05	0.000149	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—GCG—pancreatic cancer	5.08e-05	0.000149	CbGpPWpGaD
Suramin—F2—Hemostasis—PIK3CD—pancreatic cancer	5.05e-05	0.000148	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PIK3CB—pancreatic cancer	5.04e-05	0.000148	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HEY2—pancreatic cancer	5.03e-05	0.000147	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CXCL8—pancreatic cancer	5.02e-05	0.000147	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—APOE—pancreatic cancer	5.01e-05	0.000147	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HRAS—pancreatic cancer	4.99e-05	0.000146	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	4.92e-05	0.000144	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GAST—pancreatic cancer	4.91e-05	0.000144	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCK—pancreatic cancer	4.86e-05	0.000142	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AKT1—pancreatic cancer	4.85e-05	0.000142	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CXCL8—pancreatic cancer	4.85e-05	0.000142	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AGTR1—pancreatic cancer	4.85e-05	0.000142	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SLC2A2—pancreatic cancer	4.83e-05	0.000141	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HRAS—pancreatic cancer	4.82e-05	0.000141	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CASP3—pancreatic cancer	4.8e-05	0.000141	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.78e-05	0.00014	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	4.76e-05	0.000139	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.74e-05	0.000139	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CNR2—pancreatic cancer	4.73e-05	0.000138	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GLP1R—pancreatic cancer	4.73e-05	0.000138	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CXCL8—pancreatic cancer	4.73e-05	0.000138	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AKT1—pancreatic cancer	4.68e-05	0.000137	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCND1—pancreatic cancer	4.68e-05	0.000137	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SCT—pancreatic cancer	4.66e-05	0.000136	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCKAR—pancreatic cancer	4.66e-05	0.000136	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HEY1—pancreatic cancer	4.66e-05	0.000136	CbGpPWpGaD
Suramin—ARSA—Metabolism—PTEN—pancreatic cancer	4.65e-05	0.000136	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CASP3—pancreatic cancer	4.64e-05	0.000136	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CTNNB1—pancreatic cancer	4.63e-05	0.000135	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PIK3CD—pancreatic cancer	4.62e-05	0.000135	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.62e-05	0.000135	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MMP9—pancreatic cancer	4.54e-05	0.000133	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PIK3CG—pancreatic cancer	4.52e-05	0.000132	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCND1—pancreatic cancer	4.52e-05	0.000132	CbGpPWpGaD
Suramin—F2—Signaling Pathways—JAG2—pancreatic cancer	4.52e-05	0.000132	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PTEN—pancreatic cancer	4.51e-05	0.000132	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CTNNB1—pancreatic cancer	4.47e-05	0.000131	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MYC—pancreatic cancer	4.45e-05	0.00013	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MEN1—pancreatic cancer	4.45e-05	0.00013	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCK—pancreatic cancer	4.44e-05	0.00013	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AKT1—pancreatic cancer	4.4e-05	0.000129	CbGpPWpGaD
Suramin—F2—Hemostasis—PIK3CB—pancreatic cancer	4.4e-05	0.000129	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MMP9—pancreatic cancer	4.38e-05	0.000128	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.37e-05	0.000128	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PPARG—pancreatic cancer	4.36e-05	0.000128	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PTEN—pancreatic cancer	4.36e-05	0.000127	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CNR2—pancreatic cancer	4.33e-05	0.000127	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GLP1R—pancreatic cancer	4.33e-05	0.000127	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCKAR—pancreatic cancer	4.26e-05	0.000125	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	4.25e-05	0.000124	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AKT1—pancreatic cancer	4.25e-05	0.000124	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SHH—pancreatic cancer	4.25e-05	0.000124	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NOTCH4—pancreatic cancer	4.22e-05	0.000123	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.21e-05	0.000123	CbGpPWpGaD
Suramin—F2—Signaling Pathways—IAPP—pancreatic cancer	4.19e-05	0.000123	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SRC—pancreatic cancer	4.19e-05	0.000122	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—JAG2—pancreatic cancer	4.13e-05	0.000121	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VEGFA—pancreatic cancer	4.08e-05	0.000119	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MEN1—pancreatic cancer	4.07e-05	0.000119	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SRC—pancreatic cancer	4.04e-05	0.000118	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—STAT3—pancreatic cancer	4.04e-05	0.000118	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NRAS—pancreatic cancer	4.03e-05	0.000118	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PIK3CB—pancreatic cancer	4.03e-05	0.000118	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTHLH—pancreatic cancer	4.02e-05	0.000118	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTCH1—pancreatic cancer	4.02e-05	0.000118	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—MMP2—pancreatic cancer	4e-05	0.000117	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PIK3CD—pancreatic cancer	3.97e-05	0.000116	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VEGFA—pancreatic cancer	3.94e-05	0.000115	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—STAT3—pancreatic cancer	3.9e-05	0.000114	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	3.89e-05	0.000114	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NRAS—pancreatic cancer	3.89e-05	0.000114	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SHH—pancreatic cancer	3.88e-05	0.000114	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NOTCH4—pancreatic cancer	3.86e-05	0.000113	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—IAPP—pancreatic cancer	3.83e-05	0.000112	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MYC—pancreatic cancer	3.75e-05	0.00011	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CD44—pancreatic cancer	3.74e-05	0.000109	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TGFB1—pancreatic cancer	3.74e-05	0.000109	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTHLH—pancreatic cancer	3.68e-05	0.000108	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTCH1—pancreatic cancer	3.68e-05	0.000108	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SST—pancreatic cancer	3.68e-05	0.000108	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EGFR—pancreatic cancer	3.67e-05	0.000107	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.67e-05	0.000107	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.63e-05	0.000106	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.63e-05	0.000106	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MYC—pancreatic cancer	3.62e-05	0.000106	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TGFB1—pancreatic cancer	3.61e-05	0.000106	CbGpPWpGaD
Suramin—F2—Signaling Pathways—JAG1—pancreatic cancer	3.6e-05	0.000105	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—GCG—pancreatic cancer	3.59e-05	0.000105	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NOTCH3—pancreatic cancer	3.59e-05	0.000105	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EGFR—pancreatic cancer	3.54e-05	0.000104	CbGpPWpGaD
Suramin—F2—Hemostasis—SRC—pancreatic cancer	3.53e-05	0.000103	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KRAS—pancreatic cancer	3.47e-05	0.000101	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PIK3CB—pancreatic cancer	3.46e-05	0.000101	CbGpPWpGaD
Suramin—F2—Hemostasis—VEGFA—pancreatic cancer	3.44e-05	0.0001	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTGS2—pancreatic cancer	3.43e-05	0.0001	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CNR1—pancreatic cancer	3.4e-05	9.94e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—NRAS—pancreatic cancer	3.39e-05	9.93e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—STK11—pancreatic cancer	3.37e-05	9.87e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SST—pancreatic cancer	3.37e-05	9.85e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KRAS—pancreatic cancer	3.35e-05	9.79e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CXCL8—pancreatic cancer	3.33e-05	9.73e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PIK3CG—pancreatic cancer	3.3e-05	9.64e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—JAG1—pancreatic cancer	3.29e-05	9.64e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NOTCH3—pancreatic cancer	3.28e-05	9.6e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—GCG—pancreatic cancer	3.28e-05	9.6e-05	CbGpPWpGaD
Suramin—ARSA—Metabolism—PIK3CA—pancreatic cancer	3.28e-05	9.59e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—SRC—pancreatic cancer	3.23e-05	9.44e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.19e-05	9.34e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PIK3CA—pancreatic cancer	3.18e-05	9.31e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.17e-05	9.26e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—TGFB1—pancreatic cancer	3.15e-05	9.22e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VEGFA—pancreatic cancer	3.14e-05	9.19e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AGTR1—pancreatic cancer	3.13e-05	9.16e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CNR1—pancreatic cancer	3.11e-05	9.09e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—NRAS—pancreatic cancer	3.1e-05	9.08e-05	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—AKT1—pancreatic cancer	3.09e-05	9.03e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—STK11—pancreatic cancer	3.08e-05	9.02e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—pancreatic cancer	3.08e-05	9.01e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PIK3CA—pancreatic cancer	3.07e-05	8.99e-05	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CTNNB1—pancreatic cancer	3.07e-05	8.98e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PIK3CG—pancreatic cancer	3.02e-05	8.82e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—GCG—pancreatic cancer	3e-05	8.78e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTEN—pancreatic cancer	2.99e-05	8.76e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—pancreatic cancer	2.97e-05	8.7e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HRAS—pancreatic cancer	2.95e-05	8.62e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—KRAS—pancreatic cancer	2.92e-05	8.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TYMS—pancreatic cancer	2.9e-05	8.49e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PIK3CD—pancreatic cancer	2.9e-05	8.48e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TGFB1—pancreatic cancer	2.88e-05	8.44e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AGTR1—pancreatic cancer	2.86e-05	8.37e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HRAS—pancreatic cancer	2.84e-05	8.32e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—STK11—pancreatic cancer	2.82e-05	8.25e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.78e-05	8.14e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SMAD4—pancreatic cancer	2.7e-05	7.9e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—PIK3CA—pancreatic cancer	2.68e-05	7.85e-05	CbGpPWpGaD
Suramin—ARSA—Metabolism—AKT1—pancreatic cancer	2.68e-05	7.83e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—CXCL8—pancreatic cancer	2.67e-05	7.82e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—KRAS—pancreatic cancer	2.67e-05	7.81e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PIK3CD—pancreatic cancer	2.65e-05	7.75e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HES1—pancreatic cancer	2.64e-05	7.72e-05	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AKT1—pancreatic cancer	2.6e-05	7.61e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—pancreatic cancer	2.6e-05	7.59e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PIK3CB—pancreatic cancer	2.53e-05	7.39e-05	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AKT1—pancreatic cancer	2.51e-05	7.35e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—HRAS—pancreatic cancer	2.48e-05	7.26e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SMAD4—pancreatic cancer	2.47e-05	7.23e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PIK3CA—pancreatic cancer	2.45e-05	7.18e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CXCL8—pancreatic cancer	2.43e-05	7.1e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HES1—pancreatic cancer	2.41e-05	7.06e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—pancreatic cancer	2.37e-05	6.94e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—APOE—pancreatic cancer	2.36e-05	6.9e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TERT—pancreatic cancer	2.31e-05	6.76e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PIK3CB—pancreatic cancer	2.31e-05	6.76e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—HRAS—pancreatic cancer	2.27e-05	6.64e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.23e-05	6.54e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CXCL8—pancreatic cancer	2.22e-05	6.49e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HIF1A—pancreatic cancer	2.21e-05	6.47e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TSC2—pancreatic cancer	2.21e-05	6.45e-05	CbGpPWpGaD
Suramin—F2—Hemostasis—AKT1—pancreatic cancer	2.19e-05	6.41e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APOE—pancreatic cancer	2.16e-05	6.31e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PIK3CG—pancreatic cancer	2.13e-05	6.23e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TERT—pancreatic cancer	2.11e-05	6.18e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KDR—pancreatic cancer	2.11e-05	6.18e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PIK3CA—pancreatic cancer	2.11e-05	6.18e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PPARG—pancreatic cancer	2.06e-05	6.01e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HIF1A—pancreatic cancer	2.02e-05	5.91e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TSC2—pancreatic cancer	2.02e-05	5.9e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NFKBIA—pancreatic cancer	2.01e-05	5.88e-05	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—AKT1—pancreatic cancer	2e-05	5.86e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NOTCH1—pancreatic cancer	1.99e-05	5.83e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APOE—pancreatic cancer	1.97e-05	5.77e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PIK3CG—pancreatic cancer	1.95e-05	5.7e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—NRAS—pancreatic cancer	1.95e-05	5.7e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KDR—pancreatic cancer	1.93e-05	5.66e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EGF—pancreatic cancer	1.93e-05	5.63e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PIK3CD—pancreatic cancer	1.87e-05	5.48e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NFKBIA—pancreatic cancer	1.84e-05	5.38e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NOTCH1—pancreatic cancer	1.82e-05	5.33e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PIK3CG—pancreatic cancer	1.78e-05	5.21e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—NRAS—pancreatic cancer	1.78e-05	5.21e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—EGFR—pancreatic cancer	1.77e-05	5.19e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EGF—pancreatic cancer	1.76e-05	5.15e-05	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—AKT1—pancreatic cancer	1.73e-05	5.05e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PIK3CD—pancreatic cancer	1.71e-05	5.01e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.7e-05	4.96e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—KRAS—pancreatic cancer	1.68e-05	4.9e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PIK3CB—pancreatic cancer	1.63e-05	4.77e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—EGFR—pancreatic cancer	1.62e-05	4.75e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTGS2—pancreatic cancer	1.62e-05	4.73e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PIK3CD—pancreatic cancer	1.57e-05	4.58e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PIK3CA—pancreatic cancer	1.54e-05	4.5e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—KRAS—pancreatic cancer	1.53e-05	4.48e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PIK3CB—pancreatic cancer	1.49e-05	4.37e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CXCL8—pancreatic cancer	1.43e-05	4.19e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HRAS—pancreatic cancer	1.42e-05	4.17e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTEN—pancreatic cancer	1.41e-05	4.13e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.41e-05	4.12e-05	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AKT1—pancreatic cancer	1.39e-05	4.05e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CASP3—pancreatic cancer	1.37e-05	4.01e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PIK3CB—pancreatic cancer	1.36e-05	3.99e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCND1—pancreatic cancer	1.34e-05	3.91e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CTNNB1—pancreatic cancer	1.32e-05	3.87e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CXCL8—pancreatic cancer	1.31e-05	3.84e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HRAS—pancreatic cancer	1.3e-05	3.81e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MMP9—pancreatic cancer	1.3e-05	3.79e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PTEN—pancreatic cancer	1.29e-05	3.77e-05	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AKT1—pancreatic cancer	1.26e-05	3.68e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CASP3—pancreatic cancer	1.26e-05	3.67e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCND1—pancreatic cancer	1.22e-05	3.57e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CTNNB1—pancreatic cancer	1.21e-05	3.54e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SRC—pancreatic cancer	1.2e-05	3.5e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MMP9—pancreatic cancer	1.19e-05	3.47e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PTEN—pancreatic cancer	1.18e-05	3.45e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VEGFA—pancreatic cancer	1.16e-05	3.41e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—STAT3—pancreatic cancer	1.15e-05	3.37e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AKT1—pancreatic cancer	1.15e-05	3.37e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NRAS—pancreatic cancer	1.15e-05	3.37e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SRC—pancreatic cancer	1.09e-05	3.2e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MYC—pancreatic cancer	1.07e-05	3.13e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TGFB1—pancreatic cancer	1.07e-05	3.13e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VEGFA—pancreatic cancer	1.07e-05	3.12e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—STAT3—pancreatic cancer	1.05e-05	3.09e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NRAS—pancreatic cancer	1.05e-05	3.08e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EGFR—pancreatic cancer	1.05e-05	3.07e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PIK3CA—pancreatic cancer	9.95e-06	2.91e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KRAS—pancreatic cancer	9.9e-06	2.9e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MYC—pancreatic cancer	9.8e-06	2.87e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TGFB1—pancreatic cancer	9.78e-06	2.86e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EGFR—pancreatic cancer	9.59e-06	2.8e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PIK3CA—pancreatic cancer	9.1e-06	2.66e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KRAS—pancreatic cancer	9.06e-06	2.65e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—pancreatic cancer	8.8e-06	2.57e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HRAS—pancreatic cancer	8.42e-06	2.46e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PIK3CA—pancreatic cancer	8.32e-06	2.43e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AKT1—pancreatic cancer	8.13e-06	2.38e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—pancreatic cancer	8.05e-06	2.35e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HRAS—pancreatic cancer	7.7e-06	2.25e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AKT1—pancreatic cancer	7.43e-06	2.17e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AKT1—pancreatic cancer	6.8e-06	1.99e-05	CbGpPWpGaD
